Lessee, Operating Lease, Liability, to be Paid, Year Three of Yubo International Biotech Ltd from 31 Dec 2022 to 30 Jun 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).
Summary
Yubo International Biotech Ltd quarterly Lessee, Operating Lease, Liability, to be Paid, Year Three in USD history and change rate from 31 Dec 2022 to 30 Jun 2025.
  • Yubo International Biotech Ltd Lessee, Operating Lease, Liability, to be Paid, Year Three for the quarter ending 30 Jun 2025 was $79,742.
Source SEC data
View on sec.gov
Lessee, Operating Lease, Liability, to be Paid, Year Three, Quarterly (USD)
Lessee, Operating Lease, Liability, to be Paid, Year Three, YoY Quarterly Change (%)

Yubo International Biotech Ltd Quarterly Lessee, Operating Lease, Liability, to be Paid, Year Three (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q2 2025 $79,742 30 Jun 2025 10-Q 13 Aug 2025 2025 Q2
Q1 2025 $71,899 31 Mar 2025 10-Q 14 May 2025 2025 Q1
Q4 2024 $112,048 +$95,050 +559% 31 Dec 2024 10-K 31 Mar 2025 2024 FY
Q4 2023 $16,998 -$84,652 -83% 31 Dec 2023 10-K 12 Apr 2024 2023 FY
Q3 2023 $101,988 30 Sep 2023 10-Q 20 Nov 2023 2023 Q3
Q2 2023 $101,988 30 Jun 2023 10-Q 11 Aug 2023 2023 Q2
Q1 2023 $101,988 31 Mar 2023 10-Q 15 May 2023 2023 Q1
Q4 2022 $101,650 31 Dec 2022 10-K 14 Apr 2023 2022 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.